Th9 differentiation assay

YN Yumi Nonomura
AO Atsushi Otsuka
CN Chisa Nakashima
JS Judith A. Seidel
AK Akihiko Kitoh
TD Teruki Dainichi
SN Saeko Nakajima
YS Yu Sawada
SM Shigeto Matsushita
MA Megumi Aoki
TT Tatsuya Takenouchi
TF Taku Fujimura
NH Naohito Hatta
SK Satoshi Koreeda
SF Satoshi Fukushima
TH Tetsuya Honda
KK Kenji Kabashima
request Request a Protocol
ask Ask a question
Favorite

PBMCs obtained as mentioned above from 10 healthy donors were cultured in round-bottom 96-well plates and stimulated with anti-CD3 antibody (0.5 μg/mL, BioLegend) or anti-CD3/CD28 beads (4 μL/well, Thermo Fisher Scientific). Th9 cell induction with or without anti-PD-1 antibody (2 μg/mL, 10 μg/mL, or 50 μg/mL, J105, eBioscience) or anti-PD-L1 antibody (10 μg/mL, B7H1, BioLegend) was assessed by flow cytometry after 72 h of culture with recombinant IL-4 (10 ng/mL, BioLegend), recombinant TGF-β (10 ng/mL, BioLegend), both, or neither as control.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A